SCHEMBL9345161

SCHEMBL9345161

NC(=O)C(N)Cc1cc(CP(=O)(O)O)cc(-c2ccc(Cl)cc2)c1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.56
▸ ALOX15 P16050 2/20 0.56
▸ CYP2C19 P33261 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ HSD17B10 Q99714 2/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ MAPK1 P28482 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ GRIN2D O15399 1/20 0.40
▸ GRIN3B O60391 1/20 0.40
▸ GRIN1 Q05586 1/20 0.40
▸ GRIN2A Q12879 1/20 0.40
▸ GRIN2B Q13224 1/20 0.40
▸ GRIN2C Q14957 1/20 0.40
▸ GRIN3A Q8TCU5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9344811 0.90 MEN1 (0.69) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL9343960 0.85 MEN1 (0.52) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL9345173 0.83 KMT2A (0.40) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL794085 0.77 MEN1 (0.73) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL1430608 0.77 MEN1 (0.73) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL9345165 0.77 MEN1 (0.53) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL9343957 0.77 MEN1 (0.53) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL9344792 0.76 GRIN2D (0.46) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL9345597 0.74 MEN1 (0.50) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL5096121 0.74 SLC6A4 (0.57) ALOX15CYP2C19TDP1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5321016-A Epliepsy, central nervous system disorders SANDOZ PHARMACEUTICALS CORP. (US) 1994-06-14 — — US disclosed
US-5162311-A Treating epilepsy, psychiatric disorders SANDOZ PHARMACEUTICALS CORP. (US) 1992-11-10 — — US disclosed
Send feedback